Guardant Health (GH) Receivables - Net (2017 - 2026)

Guardant Health (GH) has 10 years of Receivables - Net data on file, last reported at $137.4 million in Q1 2026.

• Quarterly Receivables - Net rose 19.04% year-over-year to $137.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $137.4 million (up 19.04% YoY) and the FY2025 annual result came in at $137.8 million, up 25.03% from the prior year.
• Receivables - Net steadied at $137.4 million in Q1 2026 per GH's latest filing, from $137.8 million in the prior quarter.
• The five-year high for Receivables - Net was $137.8 million in Q4 2025, with the low at $84.3 million in Q1 2022.
• Average Receivables - Net over 5 years is $102.0 million, with a median of $95.3 million recorded in 2022.
• Year-over-year, Receivables - Net surged 77.53% in 2022 and fell 9.24% in 2023.
• Guardant Health's Receivables - Net stood at $97.3 million in 2022, then fell by 8.71% to $88.8 million in 2023, then climbed by 24.18% to $110.3 million in 2024, then increased by 25.03% to $137.8 million in 2025, then decreased by 0.32% to $137.4 million in 2026.
• Business Quant data shows GH's Receivables - Net at $137.4 million in Q1 2026, $137.8 million in Q4 2025, and $115.6 million in Q3 2025.